PHASE 3 TRIAL OF TUMOR TREATING FIELDS CONCOMITANT WITH WEEKLY PACLITAXEL FOR PLATINUM-RESISTANT OVARIAN CANCER: ENGOT-OV50/GOG-329/INNOVATE-3

被引：0

作者：

Vergote, I. ^{[1
]}

Salutari, V. ^{[2
]}

Cibula, D. ^{[3
]}

Korach, J. ^{[4
]}

Samartzis, E. P. ^{[5
]}

Sehouli, J. ^{[6
]}

Fossati, R. ^{[7
]}

Martin, A. G. ^{[8
]}

Tsibulak, I. ^{[9
]}

Slomovitz, B. ^{[10
]}

Coleman, R. ^{[11
]}

Monk, B. ^{[12
]}

Thaker, P. ^{[13
]}

O'Malley, D. ^{[14
]}

机构：

[1] Leuven Canc Inst, Leuven, Belgium

[2] Fdn Policl Univ Agostino Gemelli, Rome, Italy

[3] Charles Univ Hosp, Prague, Czech Republic

[4] Chaim Sheba Med Ctr, Ramat Gan, Israel

[5] Univ Spital Zurich, Zurich, Switzerland

[6] Charite Frauenklinik, Berlin, Germany

[7] IRCCS Ist Ric Farmacol, Milan, Italy

[8] Clin Univ Navarra, Navarra, Spain

[9] Med Univ Innsbruck, Innsbruck, Austria

[10] Univ Miami, Sylvester Comprehens Canc Ctr, Coral Gables, FL 33124 USA

[11] MD Anderson Canc Ctr, Houston, TX USA

[12] Univ Arizona, Coll Med, Tucson, AZ 85721 USA

[13] Washington Univ Gynecol Oncol, Washington, DC USA

[14] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2020年 / 30卷

关键词：

D O I：

10.1136/ijgc-2020-IGCS.308

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

IGCS20_138

引用

页码：A147 / A148

页数：2

共 50 条

[1] PHASE 3 TRIAL OF TUMOR TREATING FIELDS CONCOMITANT WITH WEEKLY PACLITAXEL FOR PLATINUM-RESISTANT OVARIAN CANCER: ENGOT-OV50/GOG-329/INNOVATE-3
Vergote, Ignace B.
Sehouli, Jalid
Fossati, Roldano
Coleman, Robert
Monk, Bradley
Copeland, Larry
O'malley, David
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A113 - A113
[2] Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study
Vergote, I. B.
Copeland, L.
Monk, B. J.
Coleman, R. L.
Cibula, D.
Sehouli, J.
Samartzis, E. P.
Radoslaw, M.
Gonzalez Martin, A.
Korach, J.
Salutari, V.
Witteveen, P. O.
O'Malley, D.
ANNALS OF ONCOLOGY, 2019, 30
[3] TUMOR TREATING FIELDS (200 KHZ) CONCOMITANT WITH WEEKLY PACLITAXEL FOR PLATINUM-RESISTANT OVARIAN CANCER: PHASE 3 INNOVATE/ENGOT-OV50 STUDY
Vergote, I.
Copeland, L.
Monk, B.
Coleman, R.
Cibula, D.
Sehouli, J.
Samartzis, E. P.
Madry, R.
Gonzalez Martin, A.
Korach, J.
Salutari, V.
Witteveen, P. O.
O'Malley, D.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A151 - A152
[4] Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study
Vergote, Ignace
Copeland, Larry J.
Van Gorp, Toon
Laenen, Annouschka
Scambia, Giovanni
Thaker, Premal H.
Cibula, David
Colombo, Nicoletta
Lea, Jayanthi
Gonzalez-Martin, Antonio
Korach, Jacob
Sehouli, Jalid
Monk, Bradley J.
Heinzelmann-Schwarz, Viola
Berger, Regina
Buscema, Joseph
Lau, Susie
Madry, Radoslaw
Denys, Hannelore
Pepin, Jessica Thomes
Salutari, Vanda
Bagameri, Andrea
Ardizzoia, Antonio
Henry, Stephanie
Cecere, Sabrina Chiara
Hruda, Martin
Iglesias, David A.
Manso, Luis
Shai, Ayelet
O'Malley, David M.
EUROPEAN JOURNAL OF CANCER, 2025, 219
[5] Tumor treating fields (TTFields) therapy in platinum-resistant ovarian cancer: results from the ENGOT-ov50/GOG-3029/INNOVATE-3 phase 3 study
Vergote, Ignace
Copeland, Larry
Gorp, Toon Van
Laenen, Annouschka
Scambia, Giovanni
Thaker, Premal H.
Cibula, David
Colombo, Nicoletta
Lea, Jayanthi
Gonzalez-Martin, Antonio
Korach, Jacob
Sehouli, Jalid
Monk, Bradley J.
Heinzelmann-Schwarz, Viola
Berger, Regina
Buscema, Joseph
Lau, Susie
Madry, Radoslaw
Denys, Hannelore
O'malley, David M.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A576 - A576
[6] Phase III INNOVATE study of tumor treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer (ENGOT-ov50/BGOG study groups)
Vergote, Ignace
CANCER RESEARCH, 2019, 79 (13)
[7] INNOVATE-3: A randomized, international phase 3 trial investigating tumor treating fields (200 kHz) concomitant with weekly paclitaxel for the treatment of platinum-resistant ovarian cancer
Kinzel, A.
Kirson, E. D.
Giladi, M.
Bomzon, Z.
Weinberg, U.
Farber, O.
STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S189 - S189
[8] INNOVATE-3: Phase 3 randomized, international study of tumor treating fields (200 kHz) concomitant with weekly paclitaxel for the treatment of platinum-resistant ovarian cancer.
Kirson, Eilon David
Giladi, Moshe
Bomzon, Zeev
Weinberg, Uri
Farber, Ori
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[9] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO/PACLITAXEL-CONTROLLED STUDY OF BATIRAXCEPT IN COMBINATION WITH WEEKLY PACLITAXEL IN PATIENTS WITH PLATINUM-RESISTANT RECURRENT OVARIAN CANCER (GOG-3059/ENGOT OV-66)
Fuh, Katherine
Moore, Kathleen
Baert, Thais
Herzog, Thomas
Cibula, David
Liu, Joyce
Eberst, Laurianne
Lewin, Sharon
Secord, Angeles Alvarez
Sehouli, Jalid
Myers, Tashanna
Bamias, Aristotelis
Rimel, B. J.
Colombo, Nicoletta
Franke, Amy
Shoop, Dipti
De Giorgi, Ugo
Pikiel, Joanna
Bowen, Rebecca
Gonzalez-Martin, Antonio
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A234 - A235
[10] Rosella (GOG-3073, ENGOT-OV72/MITO): a phase 3 study of relacorilant plus nab paclitaxel vs. nab-paclitaxel in platinum-resistant ovarian cancer
Lorusso, Domenica
Bagameri, Andrea
Bishop, Erin
Chudecka-Glaz, Anita
Devaux, Alix
Gladieff, Laurence
Gordinier, Mary
Kim, Jae-Weon
Korach, Jacob
Mccollum, Michael
Mileshkin, Linda
Monk, Bradley
Nicum, Shibani
Nogueira-Rodrigues, Angelica
Oaknin, Ana
O'Malley, David
Orlando, Mauro
Dreiling, Lyndah
Tudor, Iulia Cristina
Olawaiye, Alexander
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A255 - A255

← 1 2 3 4 5 →